Werner Huber
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Malaria Research and Control, HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Mosquito-borne diseases and control
Most-Cited Works
- → A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites(1993)480 cited
- → 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum(1996)221 cited
- → Analysis of MultiplePlasmodium falciparumInfections in Tanzanian Children during the Phase III Trial of the Malaria Vaccine SPf66(1997)186 cited
- → Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities(1998)106 cited
- → Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: A Potent, Orally Bioavailable Human CB1/CB2Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration(2007)96 cited
- → Highly Sensitive Methods for Quantitation of Human Immunodeficiency Virus Type 1 RNA from Plasma, Cells, and Tissues(1999)73 cited
- → Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 31Note: Nucleotide sequences data reported in this paper are available in the EMBL, Genbank™ and DDJB data bases under the accession numbers AF 001137 to AF 001153.1(1997)55 cited
- → Residual HIV-RNA Levels Persist for Up to 2.5 Years in Peripheral Blood Mononuclear Cells of Patients on Potent Antiretroviral Therapy(2000)54 cited
- → Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero District, Tanzania(2000)30 cited
- → Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy(2000)30 cited